CCL2 and neoplasm: Moreover, in desmoplasia‐associated cancers, fibroblast activation protein (FAP) could up‐regulate the expression of CCL2 through STAT3 signalling pathway, which enhances the recruitment of myeloid‐derived suppressor cells and promotes proliferation of tumour matrix and leads to poor prognosis.30